James Hoffman, MD
Hematology & Oncology · Miami, FLNPI 1427214147
Payments from drug & device makers
Across 192 payments — averaging $17,063 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$1.9M
- Seagen Inc.$794K
- Pfizer$218K
- GSK$151K
- Takeda Pharmaceuticals U.S.A., Inc.$97K
- Bristol Myers Squibb$55K
- plus $41K from 11 others
Across 78 payments — averaging $394.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$22K
- Pfizer$9K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 43 | $1,919,609 |
| Seagen Inc. | 23 | $793,651 |
| Pfizer | 28 | $217,918 |
| GSK | 8 | $151,164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $97,137 |
| Bristol Myers Squibb | 42 | $55,457 |
| AbbVie | 5 | $29,061 |
| Karyopharm Therapeutics Inc. | 2 | $7,214 |
| Johnson & Johnson | 19 | $3,102 |
| Janssen Scientific Affairs, LLC | 2 | $1,080 |
| Alnylam Pharmaceuticals Inc. | 1 | $400 |
| Stemline Therapeutics Inc. | 1 | $69 |
| Legend Biotech USA Inc. | 3 | $57 |
| Adaptive Biotechnologies Corporation | 2 | $51 |
| Sanofi | 1 | $29 |
| AstraZeneca | 2 | $26 |
| Amgen | 1 | $22 |
How this compares
$3,276,048 in reported general payments places this provider in the 90th percentile of 694 hematology & oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Miami
- Carl LandgrenMiami$47.8M
- Dickran KazandjianMiami$8.4M
- Justin WattsMiami$7.9M
- Jaime MerchanMiami$7.9M
- Frances ValdesMiami$5.7M
- Manmeet AhluwaliaMiami$4.8M
- Izidore LossosMiami$4.4M
- Gerald SoffMiami$4.3M
- Ana Sandoval LeonMiami$3.2M
- Julio ChavezTampa$16.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.